Global Exosome Isolation Service Market Research Report 2025

Publication ID:

PB505261956

Publication Date:

May 21, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Exosome Isolation Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Exosome Isolation Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Exosome Isolation Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Exosome Isolation Service in Diagnosis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Exosome Isolation Service include Creative Biostructure, AMSBIO, Everzom, System Biosciences, Creative Bioarray, Creative Biolabs, Frontage Labs, Lonza, Creative Proteomics, capital biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Isolation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Isolation Service.
The Exosome Isolation Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exosome Isolation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Isolation Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biostructure
AMSBIO
Everzom
System Biosciences
Creative Bioarray
Creative Biolabs
Frontage Labs
Lonza
Creative Proteomics
capital biosciences
Miltenyi Biotec
Novus Biologicals
Clara Biotech
Immunostep
ExosomeDx
Irvine Scientific
Beckman Coulter
Stratech
QIAGEN
Lifeasible
Segment by Type
Precipitation
Size Exclusion Chromatography
Magnetic Beads
Segment by Application
Diagnosis
Drug Delivery
Vaccine Development
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Isolation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Isolation Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Precipitation
1.2.3 Size Exclusion Chromatography
1.2.4 Magnetic Beads
1.3 Market by Application
1.3.1 Global Exosome Isolation Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnosis
1.3.3 Drug Delivery
1.3.4 Vaccine Development
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Isolation Service Market Perspective (2020-2031)
2.2 Global Exosome Isolation Service Growth Trends by Region
2.2.1 Global Exosome Isolation Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Exosome Isolation Service Historic Market Size by Region (2020-2025)
2.2.3 Exosome Isolation Service Forecasted Market Size by Region (2026-2031)
2.3 Exosome Isolation Service Market Dynamics
2.3.1 Exosome Isolation Service Industry Trends
2.3.2 Exosome Isolation Service Market Drivers
2.3.3 Exosome Isolation Service Market Challenges
2.3.4 Exosome Isolation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Isolation Service Players by Revenue
3.1.1 Global Top Exosome Isolation Service Players by Revenue (2020-2025)
3.1.2 Global Exosome Isolation Service Revenue Market Share by Players (2020-2025)
3.2 Global Exosome Isolation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exosome Isolation Service Revenue
3.4 Global Exosome Isolation Service Market Concentration Ratio
3.4.1 Global Exosome Isolation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Isolation Service Revenue in 2024
3.5 Global Key Players of Exosome Isolation Service Head office and Area Served
3.6 Global Key Players of Exosome Isolation Service, Product and Application
3.7 Global Key Players of Exosome Isolation Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Isolation Service Breakdown Data by Type
4.1 Global Exosome Isolation Service Historic Market Size by Type (2020-2025)
4.2 Global Exosome Isolation Service Forecasted Market Size by Type (2026-2031)
5 Exosome Isolation Service Breakdown Data by Application
5.1 Global Exosome Isolation Service Historic Market Size by Application (2020-2025)
5.2 Global Exosome Isolation Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Exosome Isolation Service Market Size (2020-2031)
6.2 North America Exosome Isolation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Exosome Isolation Service Market Size by Country (2020-2025)
6.4 North America Exosome Isolation Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Isolation Service Market Size (2020-2031)
7.2 Europe Exosome Isolation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Exosome Isolation Service Market Size by Country (2020-2025)
7.4 Europe Exosome Isolation Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Isolation Service Market Size (2020-2031)
8.2 Asia-Pacific Exosome Isolation Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Exosome Isolation Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Exosome Isolation Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Isolation Service Market Size (2020-2031)
9.2 Latin America Exosome Isolation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Exosome Isolation Service Market Size by Country (2020-2025)
9.4 Latin America Exosome Isolation Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Isolation Service Market Size (2020-2031)
10.2 Middle East & Africa Exosome Isolation Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Exosome Isolation Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Exosome Isolation Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biostructure
11.1.1 Creative Biostructure Company Details
11.1.2 Creative Biostructure Business Overview
11.1.3 Creative Biostructure Exosome Isolation Service Introduction
11.1.4 Creative Biostructure Revenue in Exosome Isolation Service Business (2020-2025)
11.1.5 Creative Biostructure Recent Development
11.2 AMSBIO
11.2.1 AMSBIO Company Details
11.2.2 AMSBIO Business Overview
11.2.3 AMSBIO Exosome Isolation Service Introduction
11.2.4 AMSBIO Revenue in Exosome Isolation Service Business (2020-2025)
11.2.5 AMSBIO Recent Development
11.3 Everzom
11.3.1 Everzom Company Details
11.3.2 Everzom Business Overview
11.3.3 Everzom Exosome Isolation Service Introduction
11.3.4 Everzom Revenue in Exosome Isolation Service Business (2020-2025)
11.3.5 Everzom Recent Development
11.4 System Biosciences
11.4.1 System Biosciences Company Details
11.4.2 System Biosciences Business Overview
11.4.3 System Biosciences Exosome Isolation Service Introduction
11.4.4 System Biosciences Revenue in Exosome Isolation Service Business (2020-2025)
11.4.5 System Biosciences Recent Development
11.5 Creative Bioarray
11.5.1 Creative Bioarray Company Details
11.5.2 Creative Bioarray Business Overview
11.5.3 Creative Bioarray Exosome Isolation Service Introduction
11.5.4 Creative Bioarray Revenue in Exosome Isolation Service Business (2020-2025)
11.5.5 Creative Bioarray Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Exosome Isolation Service Introduction
11.6.4 Creative Biolabs Revenue in Exosome Isolation Service Business (2020-2025)
11.6.5 Creative Biolabs Recent Development
11.7 Frontage Labs
11.7.1 Frontage Labs Company Details
11.7.2 Frontage Labs Business Overview
11.7.3 Frontage Labs Exosome Isolation Service Introduction
11.7.4 Frontage Labs Revenue in Exosome Isolation Service Business (2020-2025)
11.7.5 Frontage Labs Recent Development
11.8 Lonza
11.8.1 Lonza Company Details
11.8.2 Lonza Business Overview
11.8.3 Lonza Exosome Isolation Service Introduction
11.8.4 Lonza Revenue in Exosome Isolation Service Business (2020-2025)
11.8.5 Lonza Recent Development
11.9 Creative Proteomics
11.9.1 Creative Proteomics Company Details
11.9.2 Creative Proteomics Business Overview
11.9.3 Creative Proteomics Exosome Isolation Service Introduction
11.9.4 Creative Proteomics Revenue in Exosome Isolation Service Business (2020-2025)
11.9.5 Creative Proteomics Recent Development
11.10 capital biosciences
11.10.1 capital biosciences Company Details
11.10.2 capital biosciences Business Overview
11.10.3 capital biosciences Exosome Isolation Service Introduction
11.10.4 capital biosciences Revenue in Exosome Isolation Service Business (2020-2025)
11.10.5 capital biosciences Recent Development
11.11 Miltenyi Biotec
11.11.1 Miltenyi Biotec Company Details
11.11.2 Miltenyi Biotec Business Overview
11.11.3 Miltenyi Biotec Exosome Isolation Service Introduction
11.11.4 Miltenyi Biotec Revenue in Exosome Isolation Service Business (2020-2025)
11.11.5 Miltenyi Biotec Recent Development
11.12 Novus Biologicals
11.12.1 Novus Biologicals Company Details
11.12.2 Novus Biologicals Business Overview
11.12.3 Novus Biologicals Exosome Isolation Service Introduction
11.12.4 Novus Biologicals Revenue in Exosome Isolation Service Business (2020-2025)
11.12.5 Novus Biologicals Recent Development
11.13 Clara Biotech
11.13.1 Clara Biotech Company Details
11.13.2 Clara Biotech Business Overview
11.13.3 Clara Biotech Exosome Isolation Service Introduction
11.13.4 Clara Biotech Revenue in Exosome Isolation Service Business (2020-2025)
11.13.5 Clara Biotech Recent Development
11.14 Immunostep
11.14.1 Immunostep Company Details
11.14.2 Immunostep Business Overview
11.14.3 Immunostep Exosome Isolation Service Introduction
11.14.4 Immunostep Revenue in Exosome Isolation Service Business (2020-2025)
11.14.5 Immunostep Recent Development
11.15 ExosomeDx
11.15.1 ExosomeDx Company Details
11.15.2 ExosomeDx Business Overview
11.15.3 ExosomeDx Exosome Isolation Service Introduction
11.15.4 ExosomeDx Revenue in Exosome Isolation Service Business (2020-2025)
11.15.5 ExosomeDx Recent Development
11.16 Irvine Scientific
11.16.1 Irvine Scientific Company Details
11.16.2 Irvine Scientific Business Overview
11.16.3 Irvine Scientific Exosome Isolation Service Introduction
11.16.4 Irvine Scientific Revenue in Exosome Isolation Service Business (2020-2025)
11.16.5 Irvine Scientific Recent Development
11.17 Beckman Coulter
11.17.1 Beckman Coulter Company Details
11.17.2 Beckman Coulter Business Overview
11.17.3 Beckman Coulter Exosome Isolation Service Introduction
11.17.4 Beckman Coulter Revenue in Exosome Isolation Service Business (2020-2025)
11.17.5 Beckman Coulter Recent Development
11.18 Stratech
11.18.1 Stratech Company Details
11.18.2 Stratech Business Overview
11.18.3 Stratech Exosome Isolation Service Introduction
11.18.4 Stratech Revenue in Exosome Isolation Service Business (2020-2025)
11.18.5 Stratech Recent Development
11.19 QIAGEN
11.19.1 QIAGEN Company Details
11.19.2 QIAGEN Business Overview
11.19.3 QIAGEN Exosome Isolation Service Introduction
11.19.4 QIAGEN Revenue in Exosome Isolation Service Business (2020-2025)
11.19.5 QIAGEN Recent Development
11.20 Lifeasible
11.20.1 Lifeasible Company Details
11.20.2 Lifeasible Business Overview
11.20.3 Lifeasible Exosome Isolation Service Introduction
11.20.4 Lifeasible Revenue in Exosome Isolation Service Business (2020-2025)
11.20.5 Lifeasible Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Creative Biostructure
AMSBIO
Everzom
System Biosciences
Creative Bioarray
Creative Biolabs
Frontage Labs
Lonza
Creative Proteomics
capital biosciences
Miltenyi Biotec
Novus Biologicals
Clara Biotech
Immunostep
ExosomeDx
Irvine Scientific
Beckman Coulter
Stratech
QIAGEN
Lifeasible

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂